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Abstract: The objective of this study was to develop new films based on chitosan functionalized
with sulfonamide drugs (sulfametoxydiazine, sulfadiazine, sulfadimetho-xine, sulfamethoxazol,
sulfamerazine, sulfizoxazol) in order to enhance the biological effects of chitosan. The morphology
and physical properties of functionalized chitosan films as well the antioxidant effects of
sulfonamide-chitosan derivatives were investigated. The chitosan-derivative films showed a rough
surface and hydrophilic properties, which are very important features for their use as a wound
dressing. The film based on chitosan-sulfisoxazol (CS-S6) showed the highest swelling ratio (197%)
and the highest biodegradation rate (63.04%) in comparison to chitosan film for which the swelling
ratio was 190% and biodegradation rate was only 10%. Referring to the antioxidant effects the most
active was chitosan-sulfamerazine (CS-S5) which was 8.3 times more active than chitosan related
to DPPH (1,1-diphenyl-2-picrylhydrazyl) radical scavenging ability. This compound showed also a
good ferric reducing power and improved total antioxidant capacity.
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1. Introduction
Chitosan is a natural, nontoxic, biocompatible and biodegradable polymer with a great variety of
biomedical applications. This polymer is used in drug delivery, cell delivery systems, regenerative
medicine, tissue engineering, etc. [1]. Chitosan also shows important biological effects such as
antimicrobial, antioxidant, antidepressant, antitumor, hemostatic, anticholesteremic and antidiabetic
effects that sustain its use as a biomaterial [2]. From the chemical point of view chitosan is a cationic
polyelectrolyte at acidic pH with two types of reactive groups (amino and hydroxyl) that could be
chemically modulated in order to improve its properties. By the functionalization of chitosan, new
N-acylated, N-sulphated, N/O-carboxymethylated and N/O-substituted derivatives with increased
biocompatibility, water solubility, and antioxidant and antimicrobial effects have been obtained [3]. For
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biomedical application chitosan was developed in different forms as films, gels, particles, membranes
and scaffolds [4,5]. Similar to other polymers, chitosan has an excellent ability to form film, good
mechanical strength and a high swelling degree [6]. The solubility of chitosan is closely related to the
pH of the environment. The free amino groups of chitosan are protonated in acid solution, and the
molecules become soluble. This solution can be used to form films by airdrying and porous scaffolds
by freeze drying [7]. The use of unmodified chitosan to form films is limited due its high moisture
permeability and brittleness [8].
To increase the antimicrobial properties of chitosan, new sulfonamide derivatives have been
synthesized [9]. In a continuation of our previous work, in this paper we present the development and
characterization of new films based on chitosan-sulfonamide derivatives with potential biomedical
applications, especially as a wound dressing. The research showed that an ideal wound dressing should
provide a moist environment with good biocompatibility and prevent bacterial infection to accelerate
the tissue regeneration. Properties of films important to characterize an ideal wound dressing includin,
morphology analysis, contact angle, swelling ratio and biodegradation were investigated. The swelling
ratio influences the adsorption of exudates that are produced during the wound healing process while
the biodegradation capacity is important for the use of dressings in treating wounds, without being
absolutely required to have a regular replacement. Moreover, the biological performance of some
biomaterials is linked to their degradation behavior whereas this ability influences cell performances
and inflammatory response [10]. The major advantages of using this natural polymer as a wound
dressing are its good cytocompatibility and biodegradability [11]. In addition, the antioxidant effects
of chitosan-sulfonamide derivatives have been evaluated based on the implication of radical oxygen
species in the wound healing process. Overproduction of free radicals is an important factor in wound
chronicity, these being involved in normal aerobic metabolism, while their generation is relatively
high during infections. This can be explained by the fact that free radicals constantly oxidize the
new biomolecules produced in chronic wounds while acting as promoters of the pro-inflammatory
response [12].
2. Results and Discussion
2.1. Chitosan Derivative Films
Chitosan (medium molecular weight) was functionalized with sulfonamide drugs
(sulfametoxy-diazine, sulfadiazine, sulfadimethoxine, sulfamethoxazol, sulfamerazine, sulfizoxazol)
in order to improve its biological properties, especially the antimicrobial activity. In a continuation of
our research, starting with the sulfoanamide-chitosan derivatives, new films were developed. The
morphology and the physical properties of chitosan films are presented. The resulting films had a
thickness of approximately 0.1 mm and were colorless or slightly yellow (Figure 1).
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Figure 1. Macroscopic images of films: (a) CS-S1 (chitosan-sulfametoxydiazine); (b) CS-S2  
(chitosan-sulfadiazine); (c) CS-S3 (chitosan-sulfadimethoxine); (d) CS-S4 (chitosan-sulfamethoxazol); 
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2.2. Surface Morphology
The morphology of the dry films based on sulfoanamide-chitosan derivatives was studied
using the Atomic Force Microscopy (AFM) technique which is used to observe the nano-scale
features of the film surface. According to the AFM images, the chitosan-derivative films have a
rougher surface compared to chitosan before functionalization, which is uniform and smooth. The
three-dimensional (3D) images have clearly illustrated the increase of the number and height of the
peaks for the chitosan-derivative film surfaces compared to the chitosan film surface. Figure 2 shows
the AFM images of chitosan before functionalization (CS) and after functionalization using sulfadiazine
(chitosan-sulfadiazine film CS-S2).
Many physico-chemical parameters of films such as adsorption, wettability, friction or electric
contact properties are dependent on surface morphology [13]. In our case, considering all these
aspects, the rough surface of the chitosan-derivative films will improve their adsorption capacity and
consequently will increase their hydrophilicity. As these properties are improved, the adsorption
capacity of the exudates in the wound healing process will be also increased.
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(CS-S1) with a contact angle value of 57.98° at time 0, and 47.81° at the end of the experiment. 
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For exemplification, Figure 4 shows the images obtained for chitosan (CS) and
chitosan-sulfamethoxydiazine (CS-S1) films, at moment zero of the experiment.
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derivatives [14]. If the degree of substitution with polar structures is greater, the contact angle value 
is smaller, as is the case of chitosan-sulfamethoxydiazine (CS-S1, Figure 4). The opposite of this fact 
is found in the case of chitosan-sulfizoxazol when the sulfonamidic moiety has two methyl  
non-polar groups; in this case, the contact angle value increases with the decrease of its hydrophilicity. 
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The strains (mm) at the breaks of chitosan (CS) and chitosan-derivative films are presented 
in Figure 5. 
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The strain at the break for chitosan film was 14.68 mm, recorded at value of 0.65 newtons (N).  
For almost all chitosan-derivative films the mechanical properties increase in comparison with the 
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The strain at the break for chitosan film was 14.68 mm, recorded at value of 0.65 newtons (N).
For almost all chitosan-derivative films the mechanical properties increase in comparison with the
chitosan film. Among the chitosan derivatives, good mechanical properties were shown by CS-S1
(chitosan-sulfamethoxydiazine), CS-S5 (chitosan-sulfamerazine) and CS-S4 (chitosan-sulfamethoxazol)
for which the strain at the break was 16.58 mm at 3.67 N, 18.48 mm at 1.36 N and 28.16 mm at
0.72 N, respectively.
2.5. Swelling Ratio Measurement
For the chitosan film the thermodynamic equilibrium was achieved after 60 min when the recorded
swelling ratio was 190% (Figure 6). Chitosan-derivative films showed a similar swelling ratio except
for chitosan-sulfadiazine (CS-S2), chitosan-sulfamerazine (CS-S5) and chitosan-sulfamethoxydiazine
(CS-S1). For these chitosan derivatives the thermodynamic equilibrium was achieved after 120 min
(CS-S1, CS-S2) and 60 min (CS-S5), respectively, with a corresponding swelling ratio of 122%, 125%
and 130%. The highest swelling ratio was recorded for chitosan-sulfisoxazol (CS-S6), for which the
swelling ratio was 197% at thermodynamic equilibrium which was reached after 240 min.
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Lysozyme is an enzyme that is present in exudate, tears, nasal secretions, saliva, urine and other 
body fluids. Exudate is generated during the wound healing process as part of the inflammatory 
response, and it is one of the components of the reparative process. Exudate has a complex 
composition that includes glucose, cytokines, leucocytes, lysozyme and many others components. 
Lysozyme is able to destroy certain bacteria, working by splitting the components of the extracellular 
matrix [15]. Moreover, in vitro biodegradation of chitosan and its derivatives is mainly attributed to 
the effect of lysozyme through the hydrolysis of acetylated residues. The degradation products of 
chitosan and its derivatives are D-glucosamine and glycosaminoglycan, which are non-toxic for 
mammalian cells [16]. Based on this idea, we chose to determine the ability of biodegradation of 
chitosan-derivative films in a phosphate buffered saline (PBS) solution (pH 7.4) containing lysozyme 
at 37 °C. 
The results of the in vitro biodegradation of chitosan-derivative films are presented in Figure 7. 
With the exception of the chitosan-sulfamethoxydiazine (CS-S1) and chitosan-sulfadimethoxine  
(CS-S4) films, for which no biodegradation was recorded on the first day of the experiment, the rest  
of the compounds showed biodegradation on the first day and it increased during the experiment. 
At the end of the experiment, all chitosan-derivative films were biodegraded at a higher ratio 
than chitosan, for which the biodegradation ratio was 10%. The highest rate of biodegradation was 
recorded for the chitosan-sulfizoxazole film (CS-S6), which was biodegraded at a ratio of 63.04% on  
the seventh day of the experiment. This could be explained by the rough surface of the chitosan-
derivative films, which assures a greater contact surface with the biological medium containing 
lysozyme. 
Figure 6. Swelling ratio of chitosan-derivative films.
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that chitosan derivatives, except chitosan-sulfamethoxydiazine (CS-S1, EC50 = 10.92 mg/mL), have
more intense reducing power than chitosan (EC50 = 6.65 mg/mL) (Figure 9). The most active were
chitosan-sulfadimethoxine (CS-S3) and chitosan-sulfamerazine (CS-S5). For these compounds the value
of EC50 was 0.85 mg/mL (CS-S3) and 1.54 mg/mL (CS-S5) which means they are 7.7 times and 4.3 times
respectively more active than chitosan. Good activity was shown also by chitosan-sulfizoxazol (CS-S6,
EC50 = 2.21 mg/mL), chitosan-sulfadiazine (CS-S2, EC50 = 3.54 mg/mL) and chitosan-sulfamethoxazol
(CS-S4, EC50 = 4.62 mg/mL).Int. J. Mol. Sci. 2015, 16, page–page 
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2.8. Antimicrobial Assays
In this study sulfonamide-chitosan derivatives were prepared and their substitution degree was
between 9.61% and 34.24%. The antimicrobial activity was manifested at the sample surface in direct
contact with bacterial media.
Diameter of Inhibition Area
Chitosan derivatives which include, in the same structure, two different entities with a known
antimicrobial action, chitosan and sulfonamide, could have increased antimicrobial activity. In this
context, the chitosan-derivative films were assayed for their antimicrobial effects against five different
bacterial strains (Staphloccocus auresus ATCC 25923, Sarcina lutea ATCC 9341, Bacillus cereus ATCC 14579,
Bacillus subtilis, Escherichia coli ATCC 25922) and three fungal strains (Candida albicans ATCC 10231,
Candida glabrata ATCC MYA 2950, Candida sake). The antimicrobial activity of chitosan-derivative films
compared to the chitosan film (CS), expressed as diameters of inhibition area (mm), is presented in
Table 1. Nitrofurantoine and nystatine were used as reference drugs (Table 2).
Table 1. Diameter of inhibition area (mm) of chitosan film (CS) and chitosan-derivative films.
Film
Diameter of Inhibition Area (mm)
S.a. S.l. B.c. B.s. E.c. C.a. C.g. C.s.
CS 16 28 20 20 15 14 0 0
CS-S1 15 30 22 18 19 10 12 17
CS-S2 17 30 27 25 28 20 25 32
CS-S3 18 30 15 20 19 11 0 0
CS-S4 17 30 27 22 22 0 25 32
CS-S5 15 30 20 18 17 0 0 0
CS-S6 17 28 16 18 18 0 0 9
S.a.—Staphloccocus auresus ATCC 25923; S.l.—Sarcina lutea ATCC 9341; B.c.—Bacillus cereus ATCC 14579;
B.s.—Bacillus subtilis; E.c.—Escherichia coli ATCC 25922; C.a.—Candida albicans ATCC 10231; C.g.—Candida
glabrata ATCC MYA 2950; C.s.—Candida sake.
Table 2. Diameter of inhibition area (mm) of nitrofurantoine and nystatine.
Control
Diameter of Inhibition Area (mm)
S.a. S.l. B.c. B.s. E.c. C.a. C.g. C.s.
Nitrofurantoine 300 µg/disc 19 8 12 20 20 n.d. n.d. n.d.
Nystatine 100 µg/disc n.d. n.d. n.d. n.d. n.d. 29 26 31
S.a.—Staphloccocus auresus ATCC 25923; S.l.—Sarcina lutea ATCC 9341; B.c.—Bacillus cereus ATCC 14579;
B.s.—Bacillus subtilis; E.c.—Escherichia coli ATCC 25922; P.a.—Pseudomonas aeruginosa CIP 82118; C.a.—Candida
albicans ATCC 10231; C.g.—Candida glabrata ATCC MYA 2950; C.s.—Candida sake; n.d.—not determined.
As shown in Table 1, all tested films have a good antimicrobial activity against all bacterial strains,
their activity being comparable or more intense than chitosan, depending on the bacterial strain. The
results support the good influence of the sulfonamide structure on the antibacterial activity of chitosan,
especially in the case of the CS-S2 and CS-S4 films. Compared with nitrofurantoine, used as a reference
drug, all tested films have a similar or even better activity. Against fungal strains, only CS-S1, CS-S2
and CS-S4 were active, the activity of CS-S2 and CS-S4 being comparable with nystatine.
Cell proliferation tests of chitosan-sulfoanamide derivatives using mouse fibroblasts have already
been done and the results were included in a previous paper [14]. It was found that all samples are
biocompatible and do not show cytotoxicity.
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3. Experimental Section
3.1. Materials
Chitosan medium molecular weight (CS, 425 kDa, deacetylation degree of 85%), acetic
acid, sodium tripolyphosphate (TPP), sodium phosphate, ammonium molybdate, potassium
ferricyanide, trichloroacetic acid, ferric chloride, 1,1-diphenyl-2-picrylhydrazyl (DPPH) were
purchased from Sigma Aldrich Company (Taufkirchen, Germany). Lysozyme with an activity of
10,000 UI/Ml was obtained from Merck Company (Darmstadt, Germany). The chitosan derivatives
used were: used chitosan-sulfametoxydiazine, chitosan-sulfadiazine, chitosan-sulfadimethoxine,
chitosan-sulfamethoxazol, chitosan sulfamerazine and chitosan-sulfizoxazol. All solvents and
chemicals had a high degree of purity.
3.2. Preparation of Chitosan Derivatives Films
Chitosan-derivative films were prepared using new chitosan-sulfonamide derivatives (CS-S1,
CS-S2, CS-S3, CS-S4, CS-S5, CS-S6). The synthesis of new chitosan-sulfonamide derivatives was
performed according to reference [9]. Briefly, by reaction of sulfonamides (sulfametoxydiazine,
sulfadiazine, sulfadimethoxine, sulfamethoxazol, sulfamerazine, sulfizoxazol) with chloroacetyl
chloride, the corresponding chloroacetyl-sulfonamide derivatives were obtained. Further, the
chloroacetyl-sulfonamides were reacted with chitosan so that new chitosan-sulfonamide derivatives
were obtained.
In order to prepare the films, the chitosan medium molecular weight (CS) and
chitosan-sulfonamide derivatives (CS-S1, CS-S2, CS-S3, CS-S4, CS-S5, CS-S6) in a concentration of
2% (w/v) were dissolved by stirring in acetic acid solution 2%. A volume of 20 mL of obtained solutions
was poured into the polystyrene Petri plates (10 cm ˆ 10 cm) and then the plates were kept at room
temperature for 48 h. The films were crosslinked with a solution of 5% sodium tripolyphosphate (TPP),
washed several times with water, in order to remove all the acetic acid and TPP, and dried at room
temperature for one week according to the literature data [17–19].
The thickness of films has been measured using a digital micrometer (Mitutoyo High-Accuracy
Digimatic Micrometer (Kruibeke, Belgium) with 1 µm accuracy. For each film three measurements in
different positions were made.
3.3. Surface Morphology
The surface morphology of films was analyzed using a Multimode Scanning Probe Microscope
(Digital Instruments, Milano, Italy) equipped with a Nanoscope IIIa controller. The 15 mm scans are
recorded in tapping mode with a silicon cantilever (OTESPA, Veeco, Bruker, Billerica, MA, USA). The
recorded images were modified with an X and Y Plane Fit Auto procedure and the surface roughness
was analyzed using Nanoscope software version 4.43r8 (Digital Instruments, Milano, Italy).
3.4. Contact Angle Measurement
The contact angle for chitosan-derivative films was determined by the sessile drop method using
the OCA 20 System (DataPhysics Instrument GmbH, Filderstadt, Germany, distributed by Benelux
Instrument). To control the drop size of the water the system includes a high precision liquid dispenser.
On the surface of chitosan-derivative film, 1 µL of water was placed using a Hamilton syringe. The
shape of droplet was designed on the screen. A CCD video camera using 1 frame/s was used to record
the image of water droplet [20]. Subsequently, the static contact angle was determined based upon
the Laplace Young fitting using the imaging software provided by the supplier (SCA 20, version 2.1.5
build 16, DataPhysics Instrument GmbH, Filderstadt, Germany). The contact angle formed between
the pure liquid and solid surface over the course of 30 s was measured and its value at every second
was recorded. The experiment was performed in triplicate.
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3.5. The Mechanical Properties
The strain of the films in wet state was measured by using a universal testing system (model 5564,
Instron Corporation, Canton, MA, USA) according to the procedure based on ASTM Standard D1708,
at room temperature [21]. Chitosan and chitosan-derivatives film, after being well moisturized with
a 0.1 M PBS solution, were cut into 2.5 cm ˆ 0.4 cm pieces and then were mounted on the two-grip
handle and with a constant speed of 1 mm/min, under 65% relative humidity, were pulled to break.
3.6. Swelling Ratio
The swelling behavior of the crosslinked chitosan-derivative films was studied by incubation at
37 ˝C, to assess the hydrophilic character of the chitosan derivatives. The films were cut into small
pieces with equal weights (Wd) and then were introduced in double-distilled water. At different times
the film sample was taken out, the excess of water was removed using filter paper and weighted (Ww)
and then placed again in water. The swelling ratio (SR) was calculated using the following formula:
SR p%q “ pWw´Wdq{Wdˆ 100 (1)
where Wd and Ww are initial mass and mass at different time intervals, respectively [15].
3.7. In Vitro Biodegradation
The biodegradation of chitosan-derivative films was studied in phosphate buffered saline (PBS)
(pH 7.4) containing lysozyme at 37 ˝C. Film samples with equal weight were immersed in PBS solution
until the swelling equilibrium was attended, then the PBS solution was changed with the PBS solution
containing lysozyme (10,000 UI/mL) and incubated at 37 ˝C for seven days. At different times (one
day, four days, seven days) the film sample was taken out and weighed. The biodegradation degree
was determined by using the next formula:
D p%q “ pW0´Wxq{W0ˆ 100 (2)
where W0 and WX are the wet weight before incubation and after incubation, respectively [22].
3.8. Antioxidant Assays
The antioxidant effects were assessed through in vitro tests: total antioxidant capacity, ferric
reducing power and radical scavenging ability, by using a UV-VIS Spectrophotometer: CINTRA 2020
(GBC Scientific Equipment, Braeside, Melbourne, Australia).
3.8.1. Total Antioxidant Capacity
The antioxidant capacity of chitosan derivatives was assessed based on phosphomolybdenum
method [23]. To 50 µL of stock solution (5 mg/mL in 2% acetic acid) was added 2 mL of reagent
solution (sulphuric acid 0.6 M, sodium phosphate 28 mM and ammonium molybdate 4 mM). The
sample was incubated for 90 min at 95 ˝C and then was cooled at room temperature. The absorbance
at 695 nm was measured using a blank that contain 50 µL of 2% acetic acid and 2 mL of reagent
solution. Effective concentration (EC50) for each chitosan derivative was calculated. The experiment
was performed in triplicate.
3.8.2. Ferric Reducing Power
The ferric reducing power of the chitosan derivatives was assessed based on method described in
the literature [24] with minor modifications. To 1 mL of stock solution (5 mg/mL in 2% acetic acid),
was added 1 mL of sodium phosphate buffer (0.2 M, pH = 6.6) and 1 mL of potassium ferricyanide
(1% w/v). The sample was incubated for 20 min at 50 ˝C. After that, 1 mL of trichloroacetic acid (10%
w/v) was added to stop the reaction. The sample was centrifuged at 4500 rpm for 15 min. The upper
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layer (1 mL) was diluted with 1 mL of deionized water and then 0.2 mL of ferric chloride (0.1% w/v)
was added. The absorbance at 700 nm was measured after 5 min, using a blank (that contain all
reagents less stock solution that was replaced with 1 mL of acetic acid 2%). Effective concentration
(EC50) for each chitosan derivative was calculated. The experiment was performed in triplicate.
3.8.3. DPPH (1,1-diphenyl-2-picrylhydrazyl) Radical Scavenging Ability
The radical scavenging ability of the chitosan derivatives against 1,1-diphenyl-2-picrylhydrazyl
(DPPH) was assessed based on the method described in literature [25–27] with minor modifications.
To 50 µL of stock solution (20 mg/mL in 2% acetic acid) was added 2950 µL of DPPH solution (0.1 nM
in methanol). The sample was left for 30 min at room temperature in the dark, and then the absorbance
at 517 nm was measured. As control DPPH methanol solution was used. The radical scavenging ability
was calculated using the following formula:
% inhibition pI%q “ pAc´Asq{Acˆ 100 (3)
where Ac and As are the absorbance of the control and sample, respectively. The experiment was
performed in triplicate.
3.9. Antimicrobial Assays
3.9.1. Diameter of Inhibition Area
The antibacterial activity of the developed films was evaluated using agar disc diffusion method
according to the method described in the literature [28]. Five bacterial strains: Staphyloccoccus aureus
ATCC 25923, Sarcina lutea ATCC 9341, Bacillus cereus ATCC 14579, Bacillus subtilis, Escherichia coli ATCC
25922 and two yeast strains: Candida albicans ATCC 10231, Candida glabrata and Candida sake have been
included in the study. All strains belong to the Culture Collection of the Department of Microbiology,
Faculty of Pharmacy, “Gr. T. Popa” University of Medicine and Pharmacy, Iasi, Romania.
Each microbial culture was diluted in sterile 0.9% NaCl to obtain a turbidity of 106 CFU/mL,
according to the McFarland standard no. 0.5, which in the next step was diluted in Mueller Hinton
agar (for bacteria) and Sabouraud agar (for yeasts) in the ratio of 1:10. The microbial medium was
spread on sterile Petri plates (25 mL/Petri plate) and then sterile stainless steel cylinders (50 mm
internal diameter; 100 mm height) were applied on the surface. Then 0.2 mL of samples (20 mg/mL in
1% acetic acid) (CS, CS-S1, CS-S2, CS-S3, CS-S4, CS-S5, CS-S6) was added to each cylinder. The Petri
plates were incubated at 37 ˝C for 24 h (for bacteria) and at 24 ˝C for 48 h (for yeasts), and after that the
diameter of inhibition area was measured. Commercially available discs containing nitrofurantoine
(300 µg/disc) and ciprofloxacine (5 µg/disc) were used as positive control.
3.10. Statistical Analysis
All assays were carried out in triplicate. Data were analyzed by an analysis of variance (ANOVA)
(p < 0.05) and were expressed as means ˘ SD. The total antioxidant activity (EC50 values) were
calculated by linear interpolation between values above and below 50% activity.
4. Conclusions
New films based on six chitosan-sulfonamide derivatives (CS-sulfametoxydiazine,
CS-sulfadiazine, CS-sulfadimethoxine, CS-sulfamethoxazol, CS-sulfamerazine, CS-sulfizoxazol)
were developed and characterized. The films showed a rough surface and a hydrophilic character
compared to chitosan film. For some of the chitosan-derivative films (CS-sulfamethoxydiazine,
CS-sulfamethoxazol, CS-sulfizoxazol) the swelling ratio was similar and even higher than that of
chitosan film. Also, based on the rough surface, all films of chitosan derivatives were biodegraded at a
higher ratio than chitosan, for which the biodegradation ratio was only 10%. The sulfonamide-chitosan
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derivatives showed antioxidant effects compared with chitosan proved by in vitro assays (total
antioxidant capacity, ferric reducing power, DPPH radical scavenging ability). The antimicrobial
effects of chitosan-sulfonamide derivative films were also evaluated. The tested films, especially
chitosan-sulfadiazine (CS-S2) and chitosan-sulfamethoxazol (CS-S4), showed good antibacterial and
antifungal activity against all tested strains. Moreover, their antimicrobial activity was similar or even
better than that of the reference substances nitrofurantoine and nystatine, respectively.
According to the results, the most effective films for biomedical applications such as
wound-dressing materials are chitosan-sulfadiazine (CS-S2) and chitosan-sulfamethoxazol (CS-S4),
which showed good antimicrobial and antioxidant effects. Moreover, these compounds are
hydrophilic, with a good swelling degree and improved biodegradation rate compared to chitosan,
which are also characteristics that are required for a good dressing material. In addition, the
chitosan-sulfamethoxazol also showed good mechanical properties, which are also important for
potential wound-dressing applications.
However, even progress has been made in the healing process, the control of infections, free
radicals and inflammation remains a huge area of interest for researchers.
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